c-jun-NH2JNK mediates invasive potential and EGFR activation by regulating the expression of HB-EGF in a urokinase-stimulated pathway

Journal of Cellular Biochemistry

Volumn 103, Issue 3, 2008, Pages 986-993

  Cáceres, Mónica ^a   Tobar, Nicolás ^a   Guerrero, Javier ^a   Smith, Patricio C ^a   Martínez, Jorge ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

EFGR; Invasiveness; JNK; uPA

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; UROKINASE;

ARTICLE; AUTOCRINE EFFECT; CARCINOMA CELL; CELL INVASION; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANTHRACENES; AUTOCRINE COMMUNICATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; UP-REGULATION; URINARY PLASMINOGEN ACTIVATOR;

EID: 39049112616     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21469     Document Type: Article

References (25)

1. Adam RM, Kim J, Lin J, Orsola A, Zhuang L, Rice DC, Freeman MR. 2002. Heparin-binding epidermal growth factor-like growth factor stimulates androgen-independent prostate tumor growth and antagonizes androgen receptor function. Endocrinology 143:4599-4608.
2. Antonyak MA, Kenyon LC, Godwin AK, James DC, Emlet DR, Okamoto I, Tnani M, Holgado-Madruga M, Moscatello DK, Wong AJ. 2002. Elevated JNK activation contributes to the pathogenesis of human brain tumors. Oncogene 21:5038-5046.
3. Benasciutti E, Pagès G, Kenzior O, Folk W, Blasi F, Crippa MP. 2004. MAPK and JNK transduction pathway can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription. Blood 104:256-262.
4. Blasi F, Carmeliet P. 2002. uPAR: A versatile signalling orchestrator. Nat Rev Moll Cell Biol 3:932-943.
5. Cáceres M, Guerrero J, Martínez J. 2005. Overexpression of RhoA-GTP induces activation of epidermal growth factor receptor, dephosphorylation od focal adhesion kinase and increased motility in breast cancer cells. Exp Cell Res 309:229-238.
6. Curtin JF, Cotter TG. 2004. JNK regulates HIPK3 expression and promotes resistance to Fas-mediated apoptosis in DU 145 prostate carcinoma cells. J Biol Chem 279:17090-17100.
7. De Cesare D, Vallone D, Caracciolo A, Sassone-Corsi P, Nerlov C, Verde P. 1995. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer. Oncogene 11:365-376.
8. Efer R, Wagner EF. 2003. AP-1: A double-edge sword in tumorigenesis. Nat Rev Cancer 3:859-867.
9. Faúndez V, Krauss R, Holuigue L, Garrido J, Gonzalez A. 1992. Epidermal growth factor receptor in synaptic fractions of the rat central nervous system. J Biol Chem 267:20363-20370.
10. Festuccia C, Angelucci A, Gravina GL, Biordi L, Millimaggi D, Muzi P, Vicentini C, Bologna M. 2005. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination. Thromb Haemost 93:964-975.
11. Fischer OM, Hart S, Gschwind A, Prenzel N, Ullrich A. 2004. Oxidative and osmotic stress signaling in tumor cells is mediated by ADAM proteases and heparin-binding epidermal growth factor. Mol Cell Biol 24:5172-5183.
12. Guerrero J, Santibañez JF, González A, Martínez J. 2004. EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases. Exp Cell Res 292:201-208.
13. Jo M, Thomas KS, O'Donnell DM, Gonias SL. 2003. Epidermal growth factor receptor-dependent and-independent cell- signaling pathways originating from the urokinase receptor. J Biol Chem 278:1642-1646.
14. Kanda N, Watanabe S. 2005. 17β-Estradiol enhances heparin-binding epidermal growth factor-like growth factor production in human keratinocytes. Am J Physiol Cell Physiol 288:C813-C823.
15. Kansra S, Stoll SW, Johnson JL, Elder JT. 2004. Autocrine extracellular signal-regulated kinase (ERK) activation in normal human keratinocytes: Metalloproteinase-mediated release of amphiregulin triggers signaling from ErbB1 to ERK. Mol Biol Cell 15:4299-4309.
16. Liu D, Aguirre Ghiso J, Estrada Y, Ossowski L. 2002. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 1:445-457.
17. Ma Z, Webb DJ, Jo M, Gonias SL. 2001. Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells. J Cell Sci 114:3387-3396.
18. Mamoune A, Kassis J, Kharait S, Kloeker S, Manos E, Jones DA, Wells A. 2004. DU 145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling. Exp Cell Res 299:91-100.
19. Mandell JW, Hussaini IM, Zecevic M, Weber MJ, VandenBerg SR. 1998. In situ visualization of intratumor growth factor signaling: Immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms. Am J Pathol 153:1411-1423.
20. Mandlekar S, Yu R, Tan TH, Kong AN. 2000. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signalling pathways in tamoxifen-induced apoptosis of human breast cancer cells. Cancer Res 60:5995-6000.
21. Miyamoto S, Hirata M, Yamazaki A, Kageyama T, Hasuwa H, Mizushima H, Tanaka Y, Yagi H, Sonoda K, Kai M, Kanoh H, Nakano H, Mekada E. 2004. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy. Cancer Res 64:5720-5727.
22. Salazar G, Gonzalez A. 2002. Novel mechanism for regulation of epidermal growth factor receptor endocytosis revealed by protein kinase A inhibition. Mol Biol Cell 13:1677-1693.
23. Santibañez JF. 2006. JNK mediates TGF-b-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes. FEBS Lett 580:5385-5391.
24. Yates C, Wells A, Turner T. 2005. Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline. Br J cancer 92:366-375.
25. Zenz R, Scheuch H, Martin P, Frank C, Eferl R, Kenner L, Sibilia M, Wagner EF. 2003. c-Jun regulates eyelid closure and skin tumor development through EGFR signaling. Dev Cell 4:879-889.